All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the MDS Alliance.
This drug class includes some of the critical therapies widely used for the management of frequently occurring MDS-related cytopenia. G-CSF and thrombopoietin agonists, for example, are prescribed to patients with severe neutropenia and thrombocytopenia.